By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Private Banks RankingPrivate Banks Ranking
Notification Show More
Latest News
Why the biggest banks 'could be natural beneficiaries' of current turmoil: strategist
Why the biggest banks ‘could be natural beneficiaries’ of current turmoil: strategist
Finance
Ramona Paden
Power of Attorney in Texas: Guide and Requirements
Personal Finance
Standard Chartered agrees to sell business in Jordan
Banking
Deutsche Bank is not the next Credit Suisse, analysts say as panic spreads
Deutsche Bank is not the next Credit Suisse, analysts say as panic spreads
Finance
Apple CEO praises China’s innovation, long history of cooperation on Beijing visit
Business
Aa
  • Finance
  • Business
  • Banking
  • Investing
  • ETFs
  • Mutual Fund
  • Personal Finance
Reading: Oxford Purchases Boston Biomanufacturing Facility in $125M Sales Leaseback
Share
Private Banks RankingPrivate Banks Ranking
Aa
  • Finance
  • Business
  • Banking
  • Investing
  • ETFs
  • Mutual Fund
  • Personal Finance
Search
  • Finance
  • Business
  • Banking
  • Investing
  • ETFs
  • Mutual Fund
  • Personal Finance
Have an existing account? Sign In
Follow US
© 2022 Foxiz News Network. Ruby Design Company. All Rights Reserved.
Private Banks Ranking > Blog > Oxford Purchases Boston Biomanufacturing Facility in $125M Sales Leaseback

Oxford Purchases Boston Biomanufacturing Facility in $125M Sales Leaseback

By 1 month ago
Share
1 Min Read
SHARE

Oxford Properties Group has completed the purchase and long-term lease back of 92 Crowley Drive. The asset is a 120,000 square foot state-of-the-art biomanufacturing facility under construction and near completion in the Boston life sciences submarket of Marlborough, MA. As part of a real estate transaction with Resilience, Oxford will acquire the building and lease the property back to Resilience for up to 30 years.

The acquisition grows Oxford’s existing North American cGMP portfolio to 1.4 million square feet with an additional development pipeline of over 1 million square feet.  Oxford’s North American cGMP platform and pipeline has 12 facilities across six markets, with the largest concentration in the Boston region totaling 775,000 square feet.

Upon completion this year, 92 Crowley will be Resilience’s flagship facility in the US with state of the art analytical and manufacturing technology. The facility will have multi-modality manufacturing capabilities with dedicated manufacturing suites and complementary office and warehouse space.

Source link

See also  Just how bad were holiday sales? The world's biggest retailers are about to tell us

You Might Also Like

What’s in the IMF’s New Extended Fund Facility Arrangement for Sri Lanka?  – The Diplomat

Sale Leaseback Cap Rates Continue to Attract Investors

How far the Fed’s facility is likely to go in stopping bank MBS woes

Robots have got the moves: The dancing robots of Boston dynamics!

US senators seek to expand sales of ethanol-gas blend with support from Big Oil

TAGGED: 125M, Biomanufacturing, Boston, Facility, Leaseback, Oxford, Purchases, sales
Share this Article
Facebook Twitter Email Print
Share
Previous Article Major crypto-related stocks rise; Silvergate leading with 25% Decentralized storage protocol Filecoin leads top 100 on 27% jump in price
Next Article Credit unions’ 72-hour cyberattack reporting window to take effect Sept. 1 Credit unions’ 72-hour cyberattack reporting window to take effect Sept. 1
Leave a comment

Leave a Reply Cancel reply

You must be logged in to post a comment.

Private Banks RankingPrivate Banks Ranking
Follow US

© 2022 Foxiz News Network. Ruby Design Company. All Rights Reserved.

Join Us!

Subscribe to our newsletter and never miss our latest news, podcasts etc..

I have read and agree to the terms & conditions
Zero spam, Unsubscribe at any time.

Removed from reading list

Undo
Welcome Back!

Sign in to your account

Lost your password?